Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)
Public ClinicalTrials.gov record NCT02134028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: To evaluate the long-term safety and tolerability of dupilumab in participants with asthma who participated in a previous dupilumab asthma study (DRI12544, PDY14192, EFC13579, EFC13691). Secondary Objectives: To evaluate the long-term efficacy of dupilumab in participants with asthma who participated in a previous dupilumab asthma clinical study. To evaluate dupilumab in participants with asthma who participated in a previous dupilumab asthma clinical study, with regards to: * Systemic exposure * Anti-drug antibodies * Biomarkers
Study identification
- NCT ID
- NCT02134028
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,282 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 4, 2014
- Primary completion
- Oct 10, 2019
- Completion
- Oct 10, 2019
- Last update posted
- Mar 27, 2022
2014 – 2019
United States locations
- U.S. sites
- 82
- U.S. states
- 30
- U.S. cities
- 71
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840047 | Birmingham | Alabama | 35209 | — |
| Investigational Site Number 840099 | Gilbert | Arizona | 85234 | — |
| Investigational Site Number 840087 | Scottsdale | Arizona | 85251 | — |
| Investigational Site Number 840402 | Tucson | Arizona | 85724 | — |
| Investigational Site Number 840132 | Little Rock | Arkansas | 72209 | — |
| Investigational Site Number 840109 | Bakersfield | California | 93301 | — |
| Investigational Site Number 840045 | Long Beach | California | 90720 | — |
| Investigational Site Number 840019 | Los Angeles | California | 90025 | — |
| Investigational Site Number 840029 | Los Angeles | California | 90025 | — |
| Investigational Site Number 840022 | Los Angeles | California | 90048 | — |
| Investigational Site Number 840044 | Newport Beach | California | 92663 | — |
| Investigational Site Number 840041 | North Hollywood | California | 91606 | — |
| Investigational Site Number 840014 | Rolling Hills Estates | California | 90274 | — |
| Investigational Site Number 840121 | San Jose | California | 95117 | — |
| Investigational Site Number 840040 | Colorado Springs | Colorado | 80907 | — |
| Investigational Site Number 840403 | Denver | Colorado | 80206 | — |
| Investigational Site Number 840006 | Denver | Colorado | 80230 | — |
| Investigational Site Number 840024 | Denver | Colorado | 80230 | — |
| Investigational Site Number 840130 | Denver | Colorado | 80246 | — |
| Investigational Site Number 840902 | New Haven | Connecticut | 06510 | — |
| Investigational Site Number 840137 | Aventura | Florida | 33180 | — |
| Investigational Site Number 840071 | Gainesville | Florida | 32607 | — |
| Investigational Site Number 840115 | Ocoee | Florida | 34761 | — |
| Investigational Site Number 840055 | Sarasota | Florida | 34239 | — |
| Investigational Site Number 840079 | Twin Falls | Idaho | 83301 | — |
| Investigational Site Number 840101 | Chicago | Illinois | 60611 | — |
| Investigational Site Number 840032 | Fort Mitchell | Kentucky | 41017 | — |
| Investigational Site Number 840017 | Louisville | Kentucky | 40223-5440 | — |
| Investigational Site Number 840030 | Owensboro | Kentucky | 42301 | — |
| Investigational Site Number 840064 | Bangor | Maine | 04401 | — |
| Investigational Site Number 840052 | Chevy Chase | Maryland | 20815 | — |
| Investigational Site Number 840073 | Gaithersburg | Maryland | 20878 | — |
| Investigational Site Number 840080 | Owings Mills | Maryland | 21117 | — |
| Investigational Site Number 840401 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 840018 | Minneapolis | Minnesota | 55402 | — |
| Investigational Site Number 840002 | St Louis | Missouri | 63110 | — |
| Investigational Site Number 840102 | St Louis | Missouri | 63141 | — |
| Investigational Site Number 840093 | St Louis | Missouri | — | — |
| Investigational Site Number 840037 | Missoula | Montana | 59808 | — |
| Investigational Site Number 840078 | Omaha | Nebraska | 68124 | — |
| Investigational Site Number 840004 | Papillion | Nebraska | 27103 | — |
| Investigational Site Number 840111 | Brick | New Jersey | 08723 | — |
| Investigational Site Number 840068 | Ocean City | New Jersey | 07712 | — |
| Investigational Site Number 840011 | Princeton | New Jersey | 08540 | — |
| Investigational Site Number 840065 | New York | New York | 10029 | — |
| Investigational Site Number 840126 | Charlotte | North Carolina | 28226 | — |
| Investigational Site Number 840083 | Charlotte | North Carolina | 28277 | — |
| Investigational Site Number 840108 | Durham | North Carolina | 27705 | — |
| Investigational Site Number 840107 | Greensboro | North Carolina | 27401 | — |
| Investigational Site Number 840907 | High Point | North Carolina | 27262 | — |
| Investigational Site Number 840404 | Winston-Salem | North Carolina | 27157-1071 | — |
| Investigational Site Number 840015 | Cincinnati | Ohio | 45236 | — |
| Investigational Site Number 840146 | Cincinnati | Ohio | 45241 | — |
| Investigational Site Number 840049 | Middleburg Heights | Ohio | 44130 | — |
| Investigational Site Number 840942 | Toledo | Ohio | 43617 | — |
| Investigational Site Number 840112 | Edmond | Oklahoma | 73034 | — |
| Investigational Site Number 840104 | Tulsa | Oklahoma | 74136 | — |
| Investigational Site Number 840034 | Medford | Oregon | 97504 | — |
| Investigational Site Number 840031 | Portland | Oregon | 97223 | — |
| Investigational Site Number 840046 | Bethlehem | Pennsylvania | 18020 | — |
| Investigational Site Number 840085 | Hershey | Pennsylvania | 17033 | — |
| Investigational Site Number 840067 | Philadelphia | Pennsylvania | 19140 | — |
| Investigational Site Number 840928 | Pittsburgh | Pennsylvania | 15213 | — |
| Investigational Site Number 840091 | Pittsburgh | Pennsylvania | 15241 | — |
| Investigational Site Number 840082 | Charleston | South Carolina | 29407 | — |
| Investigational Site Number 840117 | Greenville | South Carolina | 29607 | — |
| Investigational Site Number 840021 | Spartanburg | South Carolina | 29303 | — |
| Investigational Site Number 840062 | Amarillo | Texas | 79106 | — |
| Investigational Site Number 840038 | Boerne | Texas | 78006 | — |
| Investigational Site Number 840124 | Cypress | Texas | 77429 | — |
| Investigational Site Number 840023 | Dallas | Texas | 75231 | — |
| Investigational Site Number 840923 | El Paso | Texas | 79903 | — |
| Investigational Site Number 840922 | Fort Worth | Texas | 76109 | — |
| Investigational Site Number 840027 | Fort Worth | Texas | 76244 | — |
| Investigational Site Number 840070 | McKinney | Texas | 75069 | — |
| Investigational Site Number 840118 | Plano | Texas | 75093 | — |
| Investigational Site Number 840008 | San Antonio | Texas | 78229 | — |
| Investigational Site Number 840035 | Draper | Utah | 84020 | — |
| Investigational Site Number 840077 | Murray | Utah | 84107 | — |
| Investigational Site Number 840057 | South Burlington | Vermont | 05403 | — |
| Investigational Site Number 840059 | Fairfax | Virginia | 22030 | — |
| Investigational Site Number 840951 | Bellingham | Washington | 98225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 283 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02134028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02134028 live on ClinicalTrials.gov.